Obesity is increasingly referred to as a chronic disease. This is also how it is defined in the recommendations of scientific ...
As obesity medicine continues to evolve, integrating sleep health into obesity treatment plans is essential.Poor sleep ...
By Michele Gershberg and Michael Erman PHILADELPHIA, March 16 (Reuters) - The CEO of Roche's Genentech unit, Ashley Magargee, ...
The 2013 declaration of obesity as a chronic disease and the 2021 approval of semaglutide are associated with increased use ...
Testing revealed weight loss effects some Wall Street analysts believe compare favorably to Lilly’s orforglipron, which ...
According to the Gallup National Health and Well-Being Index, 37% of U.S. adults now report obesity, down from 39.9% three ...
Long-acting injectable CAB+RPV maintains high virologic suppression in patients with HIV and obesity, showing comparable real ...
19hon MSN
William Blair Asserts AbbVie Inc. (ABBV) Growth Prospects on Obesity Treatment Opportunities
AbbVie Inc. (NYSE:ABBV) is one of Goldman Sachs top healthcare stocks. On March 9, William Blair reiterated an Outperform ...
Obesity and type 2 diabetes are deeply interconnected. Yet, many diabetes prevention programs fail to adequately treat ...
A blockbuster anti-obesity and diabetes drug could cost as little as $3 per month to manufacture once it goes off patent ...
Acetazolamide plus atomoxetine improved nocturnal CO2 and oxygenation in OHS. Find out more about this proof-of-concept trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results